- Home
- ALMU vs CTSO Comparison
ALMU vs CTSO Comparison
Compare ALMU & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMU
- CTSO
- Stock Information
- Founded
- ALMU 2019
- CTSO 1997
- Country
- ALMU United States
- CTSO United States
- Employees
- ALMU N/A
- CTSO N/A
- Industry
- ALMU Semiconductors
- CTSO Medical/Dental Instruments
- Sector
- ALMU Technology
- CTSO Health Care
- Exchange
- ALMU Nasdaq
- CTSO Nasdaq
- Market Cap
- ALMU 76.5M
- CTSO 68.2M
- IPO Year
- ALMU N/A
- CTSO N/A
- Fundamental
- Price
- ALMU $8.34
- CTSO $1.10
- Analyst Decision
- ALMU
- CTSO Strong Buy
- Analyst Count
- ALMU 0
- CTSO 3
- Target Price
- ALMU N/A
- CTSO $4.67
- AVG Volume (30 Days)
- ALMU 88.2K
- CTSO 69.4K
- Earning Date
- ALMU 05-09-2025
- CTSO 05-08-2025
- Dividend Yield
- ALMU N/A
- CTSO N/A
- EPS Growth
- ALMU N/A
- CTSO N/A
- EPS
- ALMU N/A
- CTSO N/A
- Revenue
- ALMU $2,716,416.00
- CTSO $35,594,520.00
- Revenue This Year
- ALMU N/A
- CTSO $18.72
- Revenue Next Year
- ALMU N/A
- CTSO $19.75
- P/E Ratio
- ALMU N/A
- CTSO N/A
- Revenue Growth
- ALMU 455.81
- CTSO 14.51
- 52 Week Low
- ALMU $2.50
- CTSO $0.70
- 52 Week High
- ALMU $18.00
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- ALMU N/A
- CTSO 57.37
- Support Level
- ALMU N/A
- CTSO $1.05
- Resistance Level
- ALMU N/A
- CTSO $1.16
- Average True Range (ATR)
- ALMU 0.00
- CTSO 0.07
- MACD
- ALMU 0.00
- CTSO 0.02
- Stochastic Oscillator
- ALMU 0.00
- CTSO 73.91
About ALMU Aeluma Inc. Common Stock
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.